CTOs on the Move

Centrex Clinical Laboratories

www.centrexlabs.com

 
Centrex is one of the largest participating providers in our industry. We submit laboratory claims directly to the insurance carriers below. If you have received a bill from Centrex and your insurance information was not provided at the time of service,
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Universal Finance

Universal Finance is a Lenoir, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ECI MEDICAL TECHNOLOGIES

ECI MEDICAL TECHNOLOGIES INC. is a Bridgewater, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bayer Corporation

Bayer Corporation is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Jounce Therapeutics

Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients through a biomarker-driven approach. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within the human tumor microenvironment to prioritize targets, and then identifies related biomarkers designed to match the right immunotherapy to the right patient. Jounce is developing two clinical-stage programs as well as advancing and building out its broad and wholly-owned discovery pipeline of immuno-oncology targets, including those expressed on T-regulatory cells, macrophages and stromal cells. Jounce`s lead product candidate, vopratelimab, is a monoclonal antibody that binds to and activates ICOS and is currently being assessed in a Phase 2 clinical trial. JTX-4014 is a PD-1 inhibitor intended for use in combination with future pipeline products, and Jounce has completed enrollment in the JTX-4014 Phase 1 clinical trial. In addition, Jounce has exclusively licensed worldwide rights to JTX-8064, a LILRB2 receptor antagonist, to Celgene. For more information, please visit www.jouncetx.com. We have many career opportunities at Jounce and are looking for exceptional individuals who share our passion and perseverance for developing highly durable cancer immunotherapies that can dramatically impact and improve patients` lives.

Arizona Research Center

Arizona Research Center is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.